Galenica AG

SWX-GALE
SIX Swiss Exchange
Healthcare Medical Distribution
Global Rank
#3067
Country Rank
#57
Market Cap
5.57 B
Price
111.69
Change (%)
0.51%
Volume
69,135

Galenica AG's latest marketcap:

5.57 B

As of 07/05/2025, Galenica AG's market capitalization has reached $5.57 B. According to our data, Galenica AG is the 3067th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 5.57 B
Revenue (ttm) 4.95 B
Net Income (ttm) 230.24 M
Shares Out 49.83 M
EPS (ttm) 4.62
Forward PE 24.31
Ex-Dividend Date 04/14/2025
Earnings Date 08/07/2025
Market Cap Chart
Data Updated: 07/05/2025

Galenica AG's yearly market capitalization.

Galenica AG has seen its market value grow from ₣2.5 B to ₣5.57 B since 2017, representing a total increase of 122.39% and an annual compound growth rate (CAGR) of 11.22%.
Date Market Cap Change (%) Global Rank
07/05/2025 ₣5.57 B 18.08% 3067
12/30/2024 ₣3.71 B 2.23% 3460
12/29/2023 ₣3.62 B -3.36% 3234
12/30/2022 ₣3.75 B 10.52% 3198
12/30/2021 ₣3.39 B 16.56% 4070
12/30/2020 ₣2.91 B -1.09% 3891
12/30/2019 ₣2.94 B 38.76% 3461
12/28/2018 ₣2.12 B -15.24% 3815
12/29/2017 ₣2.5 B 3887

Company Profile

About Galenica AG

Galenica AG is a leading healthcare service provider based in Switzerland, with operations extending internationally. Founded in 1927 and headquartered in Bern, the company delivers a wide range of healthcare solutions through its two core business segments.

Business Segments

  • Products & Care

    This segment manages pharmacies and partner pharmacies under well-known brands such as Amavita, Sun Store, and Coop Vitality. It also includes the specialty pharmacy mediservice. Key offerings include:

    • Home-treatment medication for patients
    • Development, marketing, and sales of healthcare services and products through diverse distribution channels
  • Logistics & IT

    This segment provides specialized pre-wholesale services tailored for pharmaceutical and healthcare companies, including:

    • Storage, distribution, and debt collection services
    • A master data system for the healthcare market
    • Management solutions for pharmacies and healthcare providers
    • Internal IT services and technical information publications
    • Distribution of former Viatris OTC products

Frequently Asked Questions

  • What is Galenica AG's (SWX-GALE) current market cap?
    As of 07/05/2025, Galenica AG (including the parent company, if applicable) has an estimated market capitalization of $5.57 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Galenica AG global market capitalization ranking is approximately 3067 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.